Cellular and Humoral Responses to Leishmania major Virulence Factors in Healed Cutaneous Leishmaniasis and Mediterranean Visceral Leishmaniasis Patients

被引:6
作者
Lakhal-Naouar, Ines [1 ]
Boussoffara, Thouraya [1 ]
Meddeb-Garnaoui, Amel [1 ]
Ben Achour-Chenik, Yosser [1 ]
Louzir, Hechmi [1 ]
Chenik, Mehdi [1 ]
机构
[1] Inst Pasteur, Lab Immunopathol Vaccinol & Mol Genet, Tunis 1002, Tunisia
关键词
PROTECTIVE IMMUNITY; BALB/C MICE; PROTEIN; INFECTION; ANTIGEN;
D O I
10.1128/CVI.00023-09
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Cellular and humoral immune responses of healed cutaneous leishmaniasis and Mediterranean visceral leishmaniasis patients were evaluated against results for Leishmania major virulence proteins L. major protein disulfide isomerase (LmPDI) and mitogen-activated protein kinase kinase ( MAPKK). Only MAPKK induces significant peripheral blood mononuclear cell proliferation with gamma interferon production as well as antibody responses. Thus, MAPKK may be of interest in Leishmania vaccination and serodiagnosis.
引用
收藏
页码:956 / 958
页数:3
相关论文
共 15 条
[1]
Contrasting human cytokine responses to promastigote whole-cell extract and the Leishmania analogue receptor for activated C kinase antigen of L-amazonensis in natural infection versus immunization [J].
Azeredo-Coutinho, R. B. G. ;
Matos, D. C. S. ;
Armoa, G. G. R. ;
Maia, R. M. ;
Schubach, A. ;
Mayrink, W. ;
Mendonca, S. C. F. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 153 (03) :369-375
[2]
Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor [J].
Ben Achour, Y ;
Chenik, M ;
Louzir, H ;
Dellagi, K .
INFECTION AND IMMUNITY, 2002, 70 (07) :3576-3585
[3]
Analysis of granzyme B activity as a surrogate marker of Leishmania-specific cell-mediated cytotoxicity in zoonotic cutaneous leishmaniasis [J].
Bousoffara, T ;
Louzir, H ;
Ben Salah, A ;
Dellagi, K .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (07) :1265-1273
[4]
Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal [J].
Chappuis, F ;
Rijal, S ;
Jha, UK ;
Desjeux, P ;
Karki, BMS ;
Koirala, S ;
Loutan, L ;
Boelaert, M .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2006, 11 (01) :31-40
[5]
Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein [J].
Fernandes, Ana Paula ;
Silva Costa, Miriam Maria ;
Ferraz Coelho, Eduardo Antonio ;
Marques Michalick, Marilene Suzan ;
de Freitas, Eloisa ;
Melo, Maria Norma ;
Tafuri, Wagner Luiz ;
Resende, Daniela de Melo ;
Hermont, Vinicius ;
Abrantes, Christiane de Freitas ;
Gazzinelli, Ricardo Tostes .
VACCINE, 2008, 26 (46) :5888-5895
[6]
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
[7]
Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice [J].
Jaafari, Mahmoud R. ;
Ghafarian, Attieh ;
Farrokh-Gisour, Ahsan ;
Samiei, Afshin ;
Kheiri, Masoumeh Tavassoti ;
Mahboudi, Fereidoun ;
Barkhordari, Farzaneh ;
Khamesipour, Ali ;
McMaster, W. Robert .
VACCINE, 2006, 24 (29-30) :5708-5717
[8]
Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals [J].
Khoshgoo, Naghmeh ;
Zahedifard, Farnaz ;
Azizi, Hiva ;
Taslimi, Yasaman ;
Jimenez Alonso, Maribel ;
Rafati, Sima .
VACCINE, 2008, 26 (46) :5822-5829
[9]
LmxPK4, a mitogen-activated protein kinase kinase homologue of Leishmania mexicana with a potential role in parasite differentiation [J].
Kuhn, D ;
Wiese, M .
MOLECULAR MICROBIOLOGY, 2005, 56 (05) :1169-1182
[10]
MALEFYT RD, 1991, J EXP MED, V174, P1209